요로감염에서 활성화되는 분자방어기전의 최신 지견
Current Opinions Regarding Defense Mechanisms during Urinary Tract Infection
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Mucosal tissues in the gastrointestinal tract are exposed to a significant number of microorganisms, many of which present a danger to the host. In contrast, the urogenital tract is colonized rather infrequently with bacterial organisms and devoid of physical barriers such as a multi-layered mucus or ciliated epithelia, thereby necessitating separate host defense mechanisms. Recurrent urinary tract infection (UTI) represents successful microbial host evasion and poses a major health problem. In recent years, considerable advances have been made in our understanding of the mechanisms underlying the immune homeostasis of the urogenital tract. The system of pathogen-recognition receptors, including the Toll-like receptors, is able to sense danger signaling and thus activate the host immune system of the genitourinary tract. Various soluble antimicrobial molecules, including iron-sequestering proteins, defensins, cathelicidin, and Tamm-Horsfall protein, have been more clearly defined. In addition, involvement of signaling mediators such as cyclic adenosine monophosphate or the circulatory hormone vasopressin in the defense of uropathogenic microbes and maintenance of mucosal integrity has been demonstrated. Beyond this, specific receptors that are hijacked by uropathogenic Escherichia coli in order to enable invasion and survival within the urogenital system, paving the way for chronic forms of UTI, have been identified. The majority of these findings offer novel avenues for conduct of basic and translational research for development of effective therapies against the diverse forms of acute and chronic UTI.
Abstract
Mucosal tissues in the gastrointestinal tract are exposed to a significant number of microorganisms, many of which present a danger to the host. In contrast, the urogenital tract is colonized rather infrequently with bacterial organisms and devoid of physical barriers such as a multi-layered mucus or ciliated epithelia, thereby necessitating separate host defense mechanisms. Recurrent urinary tract infection (UTI) represents successful microbial host evasion and poses a major health problem. In recent years, considerable advances have been made in our understanding of the mechanisms underlying the immune homeostasis of the urogenital tract. The system of pathogen-recognition receptors, including the Toll-like receptors, is able to sense danger signaling and thus activate the host immune system of the genitourinary tract. Various soluble antimicrobial molecules, including iron-sequestering proteins, defensins, cathelicidin, and Tamm-Horsfall protein, have been more clearly defined. In addition, involvement of signaling mediators such as cyclic adenosine monophosphate or the circulatory hormone vasopressin in the defense of uropathogenic microbes and maintenance of mucosal integrity has been demonstrated. Beyond this, specific receptors that are hijacked by uropathogenic Escherichia coli in order to enable invasion and survival within the urogenital system, paving the way for chronic forms of UTI, have been identified. The majority of these findings offer novel avenues for conduct of basic and translational research for development of effective therapies against the diverse forms of acute and chronic UTI.
참고문헌 (81)
- Stamm WE, "Management of urinary tract infections in adults", N Engl J Med, 329, pp.1328~1334 (1993)
- Foxman B, "Epidemiology of urinary tract infections: incidence, morbidity, and economic costs", Am J Med, 113(Suppl 1A), pp.5S~13S (2002)
- Finer G, "Pathogenesis of urinary tract infections with normal female anatomy", Lancet Infect Dis, 4, pp.631~635 (2004)
- Hooton TM, "Diagnosis and treatment of uncomplicated urinary tract infection", Infect Dis Clin North Am, 11, pp.551~581 (1997)
- Svanborg C, "Bacterial virulence in urinary tract infection", Infect Dis Clin North Am, 11, pp.513~529 (1997)
- Mulvey MA, "Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses", Proc Natl Acad Sci U S A, 97, pp.8829~8835 (2000)
- Welch RA, "Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli", Proc Natl Acad Sci U S A, 99, pp.17020~17024 (2002)
- Brumfitt W, "Periurethral enterobacterial carriage preceding urinary infection", Lancet, 1, pp.824~826 (1987)
- Marrs CF, "Escherichia coli mediated urinary tract infections: are there distinct uropathogenic E. coli (UPEC) pathotypes?", FEMS Microbiol Lett, 252, pp.183~190 (2005)
- Roos V, "Asymptomatic bacteriuria Escherichia coli strain 83972 carries mutations in the foc locus and is unable to express F1C fimbriae", Microbiology, 152, pp.1799~1806 (2006)
- Bower JM, "Covert operations of uropathogenic Escherichia coli within the urinary tract", Traffic, 6, pp.18~31 (2005)
- Jones CH, "FimH adhesin of type 1 pili is assembled into a fibrillar tip structure in the Enterobacteriaceae", Proc Natl Acad Sci U S A, 92, pp.2081~2085 (1995)
- Martinez JJ, "Type 1 pilus-mediated bacterial invasion of bladder epithelial cells", EMBO J, 19, pp.2803~2812 (2000)
- Connell I, "Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract", Proc Natl Acad Sci U S A, 93, pp.9827~9832 (1996)
- Baorto DM, "Survival of FimH-expressing enterobacteria in macrophages relies on glycolipid traffic", Nature, 389, pp.636~639 (1997)
- Gbarah A, "Identification of the leukocyte adhesion molecules CD11 and CD18 as receptors for type 1-fimbriated (mannose-specific) Escherichia coli", Infect Immun, 59, pp.4524~4530 (1991)
- Zhou G, "Glockshuber R et al. Uroplakin Ia is the urothelial receptor for uropathogenic Escherichia coli: evidence from in vitro FimH binding", J Cell Sci, 114, pp.4095~4103 (2001)
- Rouschop KM, "Urothelial CD44 facilitates Escherichia coli infection of the murine urinary tract.", J Immunol, 177, pp.7225~7232 (2006)
- Wu XR, "In vitro binding of type 1-fimbriated Escherichia coli to uroplakins Ia and Ib: relation to urinary tract infections", Proc Natl Acad Sci U S A, 93, pp.9630~9635 (1996)
- Springall T, "Epithelial secretion of C3 promotes colonization of the upper urinary tract by Escherichia coli", Nat Med, 7, pp.801~806 (2001)
- Li K, "CD46 (membrane cofactor protein) acts as a human epithelial cell receptor for internalization of opsonized uropathogenic Escherichia coli", J Immunol, 177, pp.2543~2551 (2006)
- Eto DS, "Integrin-mediated host cell invasion by type 1-piliated uropathogenic Escherichia coli", PLoS Pathog, 3, pp.e100~ (2007)
- Lozahic S, "CD46 (membrane cofactor protein) associates with multiple beta1 integrins and tetraspans", Eur J Immunol, 30, pp.900~907 (2000)
- Hedlund M, "Type 1 fimbriae deliver an LPS- and TLR4-dependent activation signal to CD14-negative cells", Mol Microbiol, 39, pp.542~552 (2001)
- Fischer H, "Mechanism of pathogen-specific TLR4 activation in the mucosa: fimbriae, recognition receptors and adaptor protein selection", Eur J Immunol, 36, pp.267~277 (2006)
- Kagan JC, "Phosphoinositide-mediated adaptor recruitment controls Toll-like receptor signaling", Cell, 125, pp.943~955 (2006)
- Mulvey MA, "Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection", Infect Immun, 69, pp.4572~4579 (2001)
- Schilling JD, "Bacterial invasion augments epithelial cytokine responses to Escherichia coli through a lipopolysaccharide-dependent mechanism", J Immunol, 166, pp.1148~1155 (2001)
- Svanborg C, "Cytokine responses during mucosal infections: role in disease pathogenesis and host defence", Curr Opin Microbiol, 2, pp.99~105 (1999)
- Mulvey MA, "Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli", Science, 282, pp.1494~1497 (1998)
- Zasloff M, "Antimicrobial peptides, innate immunity, and the normally sterile urinary tract", Am Soc Nephrol, 18, pp.2810~2816 (2007)
- Lehrer RI, "Multispecific myeloid defensins", Curr Opin Hematol, 14, pp.16~21 (2007)
- Selsted ME, "Mammalian defensins in the antimicrobial immune response", Nat Immunol, 6, pp.551~557 (2005)
- Chromek M, "The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection", Nat Med, 12, pp.636~641 (2006)
- Abrink M, "Expression of lactoferrin in the kidney: implications for innate immunity and iron metabolism", Kidney Int, 57, pp.2004~2010 (2000)
- Goetz DH, "The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition", Mol Cell, 10, pp.1033~1043 (2002)
- Flo TH, "Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron", Nature, 432, pp.917~921 (2004)
- Berger T, "Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury", Proc Natl Acad Sci U S A, 103, pp.1834~1839 (2006)
- Säemann MD, "Tamm- Horsfall protein: a multilayered defence molecule against urinary tract infection", Eur J Clin Invest, 35, pp.227~235 (2005)
- Weichhart T, "The multiple functions of Tamm-Horsfall protein in human health and disease: a mystery clears up", Wien Klin Wochenschr, 117, pp.316~322 (2005)
- Bates JM, "Tamm-Horsfall protein knockout mice are more prone to urinary tract infection: rapid communication", Kidney Int, 65, pp.791~797 (2004)
- Parkkinen J, "Identification of factors in human urine that inhibit the binding of Escherichia coli adhesins", Infect Immun, 56, pp.2623~2630 (1988)
- Säemann MD, "Tamm-Horsfall glycoprotein links innate immune cell activation with adaptive immunity via a Toll-like receptor-4-dependent mechanism", J Clin Invest, 115, pp.468~475 (2005)
- Haraoka M, "Neutrophil recruitment and resistance to urinary tract infection", J Infect Dis, 180, pp.1220~1229 (1999)
- Hedges S, "Uroepithelial cells are part of a mucosal cytokine network", Infect Immun, 62, pp.2315~2321 (1994)
- Hang L, "Interleukin-8 receptor knockout mice have subepithelial neutrophil entrapment and renal scarring following acute pyelonephritis", J Infect Dis, 182, pp.1738~1748 (2000)
- Takeda K, "Toll-like receptors", Annu Rev Immunol, 21, pp.335~376 (2003)
- Bäckhed F, "Induction of innate immune responses by Escherichia coli and purified lipopolysaccharide correlate with organ- and cell-specific expression of Toll-like receptors within the human urinary tract", Cell Microbiol, 3, pp.153~158 (2001)
- Akira S, "Pathogen recognition and innate immunity", Cell, 124, pp.783~801 (2006)
- Kawai T, "TLR signaling", Semin Immunol, 19, pp.24~32 (2007)
- Beutler B, "How we detect microbes and respond to them: the Toll-like receptors and their transducers", J Leukoc Biol, 74, pp.479~485 (2003)
- Shahin RD, "Neutrophil recruitment and bacterial clearance correlated with LPS responsiveness in local gram-negative infection", J Immunol, 138, pp.3475~3480 (1987)
- Schilling JD, "Toll-like receptor 4 on stromal and hematopoietic cells mediates innate resistance to uropathogenic Escherichia coli", Proc Natl Acad Sci U S A, 100, pp.4203~4208 (2003)
- Chassin C, "Renal collecting duct epithelial cells react to pye lonephritis-associated Escherichia coli by activating distinct TLR4-dependent and -independent inflammatory pathways", J Immunol, 177, pp.4773~4784 (2006)
- Zager RA, "Toll-like receptor (TLR4) shedding and depletion: acute proximal tubular cell responses to hypoxic and toxic injury", Am J Physiol Renal Physiol, 292, pp.F304~312 (2007)
- Tsuboi N, "Roles of toll-like receptors in C-C chemokine production by renal tubular epithelial cells", J Immunol, 169, pp.2026~2033 (2002)
- Werts C, "Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism", Nat Immunol, 2, pp.346~352 (2001)
- Hung CC, "Upregulation of chemokine CXCL1", KC by leptospiral membrane lipoprotein preparation in renal tubule epithelial cells, 2006, pp.69, 1814~1822
- Hayashi F, "The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5", Nature, 410, pp.1099~1103 (2001)
- Lane MC, "Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract", Proc Natl Acad Sci U S A, 104, pp.16669~16674 (2007)
- Andersen-Nissen E, "Cutting edge: Tlr5-", - mice are more susceptible to Escherichia coli urinary tract infection, 2007, pp.178, 4717~4720
- Hawn TR, "A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to legionnaires' disease", J Exp Med, 198, pp.1563~1572 (2003)
- Zhang D, "A toll-like receptor that prevents infection by uropathogenic bacteria", Science, 303, pp.1522~1526 (2004)
- Song J, "TLR4- initiated and cAMP-mediated abrogation of bacterial invasion of the bladder", Cell Host Microbe, 1, pp.287~298 (2007)
- Bishop BL, "Cyclic AMP-regulated exocytosis of Escherichia coli from infected bladder epithelial cells", Nat Med, 13, pp.625~630 (2007)
- Cirl C, "Subversion of Toll-like receptor signaling by a unique family of bacterial Toll", interleukin-1 receptor domain-containing proteins, 2008, pp.14, 399~406
- Newman RM, "Identification and characterization of a novel bacterial virulence factor that shares homology with mammalian Toll", interleukin-1 receptor family proteins, 2006, pp.74, 594~601
- Merk K, "Lactobacilli - bacteria-host interactions with special regard to the urogenital tract", Int J Med Microbiol, 295, pp.9~18 (2005)
- Rakoff-Nahoum S, "Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis", Cell, 118, pp.229~241 (2004)
- Svanborg C, "Uropathogenic Escherichia coli as a model of host-parasite interaction", Curr Opin Microbiol, 9, pp.33~39 (2006)
- Frendéus B, "Escherichia coli P fimbriae utilize the Toll-like receptor 4 pathway for cell activation", Mol Microbiol, 40, pp.37~51 (2001)
- McNamara N, "AsialoGM1 and TLR5 cooperate in flagellininduced nucleotide signaling to activate Erk1", 2, 2006, pp.34, 653~660
- Smith KD, "Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility", Nat Immunol, 4, pp.1247~1253 (2003)
- Fitzgerald KA, "Endotoxin recognition and signal transduction by the TLR4", MD2-complex, 2004, pp.6, 1361~1367
- Samuelsson P, "Toll-like receptor 4 expression and cytokine responses in the human urinary tract mucosa", Infect Immun, 72, pp.3179~3186 (2004)
- Schilling JD, "CD14- and Toll-like receptor-dependent activation of bladder epithelial cells by lipopolysaccharide and type 1 piliated Escherichia coli", Infect Immun, 71, pp.1470~1480 (2003)
- Jones-Carson J, "Susceptibility of immunodeficient gene-knockout mice to urinary tract infection", J Urol, 161, pp.338~341 (1999)
- Hopkins WJ, "Local and systemic antibody responses accompany spontaneous resolution of experimental cystitis in cynomolgus monkeys", Infect Immun, 55, pp.1951~1956 (1987)
- Langermann S, "Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination", Science, 276, pp.607~611 (1997)
- Chassin C, "Hormonal control of the renal immune response and antibacterial host defense by arginine vasopressin", J Exp Med, 204, pp.2837~2852 (2007)
- Bens M, "Regulation of NaCl transport in the renal collecting duct: lessons from cultured cells", Pflugers Arch, 453, pp.133~146 (2006)